Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis

CONCLUSIONS: The NNT, NNH, and LHH for quarterly and monthly fremanezumab compare favorably with those for traditional oral preventive medications, including topiramate, valproate, and propranolol.PMID:37955395 | DOI:10.1111/head.14651

Source: Headache - November 13, 2023 Category: Neurology Authors: Messoud Ashina Dimos D Mitsikostas Verena Ramirez Campos Steve Barash Xiaoping Ning Hans-Christoph Diener Source Type: research